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Abstract 
Background: We report our long-term experience with 119 cases of N-shaped orthotopic ileal neobladder.
Methods: Between March 1996 and July 2013, a total of 119 patients (102 men, 17 women) underwent cystectomy 
with creation of an N-shaped orthotopic ileal neobladder. The Clavien–Dindo classification score was used for grading 
early (<3 months postoperative), late, and pouch-related and non-pouch-related complications. Daytime and night-
time continence were evaluated for male and female patients separately, with patients subdivided in three groups: 
completely continent, use of ≤1 pad, and use of >1 pad.
Results: Median follow-up was 75 months (range 3–204). Early complications (15 major, 54 minor) occurred in 
39.5 % of 119 patients whereas 53.1 % presented with late complications (56 major, 39 minor; 111 patients evalu-
ated). Urinary infection and outlet obstruction were both the most frequent early and late pouch-related complica-
tions; early non-pouch-related complications were mainly infectious and gastrointestinal, and the most common late 
non-pouch-related problem was wound herniation. At 12 months, 96 and 60 % of the men and 84.6 and 66.7 % of the 
women respectively achieved daytime and nighttime continence.
Conclusion: Complication rates of the N-shaped orthotopic ileal neobladder were relatively high, probably because 
of meticulous recording and follow-up. Daytime continence rates were better than nighttime rates. N-shaped 
orthotopic ileal neobladder can be a good option for urinary diversion in selected patients who undergo radical 
cystectomy.
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Background
Radical cystectomy (RC) with pelvic lymph node dis-
section and urinary diversion is the standard therapy 
for non-metastatic muscle-invasive bladder cancer and 
high-risk non-muscle-invasive bladder cancer (Witjes 
et  al. 2014). Over the last two decades, orthotopic ileal 
neobladder (OIN) has gained popularity, with the Haut-
mann and Studer pouches used commonly (Hautmann 
2003; Hautmann et al. 2013). Compared to the ileal con-
duit (IC), it offers similar cancer control rates and pos-
sibly a higher quality of life by preserving continence and 
near-normal voiding function, avoiding urinary stoma 
(Yossepowitch et al. 2003; Hautmann et al. 2006; Studer 
et  al. 2006). Disadvantages are the more complex surgi-
cal procedure, higher risk of postoperative complica-
tions, and a significant risk of (nighttime) incontinence 
or even hypercontinence, the latter especially in women 
(Hautmann et al. 1999; Arai et al. 1999). The importance 
of intensive pelvic floor re-education to reduce incon-
tinence rates has been acknowledged (Arai et  al. 1999). 
Orthotopic bladder substitution (OBS) is therefore 
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indicated only for highly motivated and cognitively capa-
ble patients. In neobladder creation, different parts of the 
gastrointestinal tract have been variously suggested for 
use (Hinman 1998). At present, a detubularized segment 
of ileum is recommended (Hautmann 2003; Hautmann 
et al. 2013), offering a low-pressure reservoir with good 
capacity (Hautmann et  al. 2013; Nam et  al. 2013; Singh 
et al. 2014).
In 2005, we published our early results in 58 patients 
undergoing RC and OBS with the N-shaped ileal neo-
bladder, with a mean follow-up of 38  months (Joniau 
et  al. 2005). We now report a series of 119 consecu-
tive patients and describe long-term experience with 
the Leuven N-pouch technique, creating an ileal pouch 
with an isoperistaltic afferent limb onto which both 
ureters are anastomosed in an end-to-end fashion. This 
technique combines features of the popular Hautmann 
and Studer neobladders, creating a good-capacity 
pouch with an active anti-reflux mechanism (Haut-
mann et  al. 1988; Studer et  al. 1989). The aim of this 
retrospective study was primarily to assess our long-
term experience in terms of complication rates and 
continence.
Methods
Patient population and study design
Between March 1996 and July 2013, a total of 810 RCs 
were performed at our tertiary referral institution (UZ 
Leuven, Belgium), and 119 consecutive patients (102 men 
and 17 women) underwent cystectomy with N-shaped 
OIN reconstruction. We reviewed their medical records 
retrospectively in accordance with the ethical standards 
laid down in the 1964 Declaration of Helsinki and its 
later amendments. The confidentiality of patient data was 
guaranteed.
Absolute contraindications were prostatic stro-
mal tumor invasion, inflammatory bowel disease, and 
impaired renal function (serum creatinine >2.0  mg/dL) 
and liver function. Other (relative) exclusion criteria 
were poor physical condition, salvage cystectomy, exten-
sive local tumor burden, cognitive incapability, and lack 
of motivation or physical inability to perform intermit-
tent catheterization.
Follow‑up
Database collection was based on outpatient and admis-
sion reports until June 2015. Standard outpatient vis-
its took place at 3-month intervals during the first two 
postoperative years, at 6-month intervals up to the fifth 
year, and yearly thereafter. Physical examination was 
performed at every visit, as were laboratory tests (blood 
count, renal and liver function, sodium, potassium, chlo-
ride, bicarbonate, and vitamin B12 from the third year 
on) and imaging. Abdominal ultrasound and chest X-ray 
were alternated with abdominal and thoracic computed 
tomography scans.
Surgical technique
Cystoprostatectomy was performed in men while women 
underwent cystectomy with sparing of the urethropelvic 
ligament and the neurovascular structures of the urethra. 
Of the 17 women, 9 had anterior exenteration while 8 had 
cystectomy alone. A bilateral pelvic lymph node dissec-
tion was performed for any patient with an indication of 
oncological disease.
Subsequently, an N-shaped neobladder was created 
with a 50-cm segment of preterminal ileum. This seg-
ment was folded into four equally long parts, three of 
them forming the N-shaped pouch while the most proxi-
mal part remained intact, forming the afferent isoperi-
staltic limb onto which the ureters were anastomosed 
in an end-to-end fashion separately (Fig.  1). An exact 
description of this technique has been published previ-
ously (Joniau et al. 2005).
Complications
Complications were registered as early (occurring within 
3 months postoperative) or late, as well as pouch-related 
or non-pouch-related. The validated Clavien–Dindo 
classification score (CCS) was used to grade complica-
tions (Dindo et  al. 2004). CCS I and II were considered 
to indicate minor complications and CCS III to V major 
complications. In addition, the treatment for these com-
plications was noted, in particular conservative, endo-
scopic, or open surgical therapy.
Fig. 1 The N-shaped orthotopic ileal neobladder. Large arrow Intact 
afferent isoperistaltic segment, acting as an active anti-reflux mecha-
nism. The ureters are anastomosed to this segment in an end-to-end 
manner. Arrowhead Three antimesenterically opened ileal segments, 
creating the N-shaped pouch. Small arrow The lowest point of the 
pouch, forming the urethral anastomosis
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Continence
Continence was assessed during follow-up visits. For sub-
dividing the patients according to their continence status, 
we used the UCLA-Prostate Cancer Index with a minor 
modification (Litwin et al. 1998). In this way, continence 
was defined with more strict criteria, and patients were 
divided into three groups: Group 1 (G1), patients with-
out any need for protection; Group 2 (G2), those in need 
of maximally one (safety) pad; and Group 3 (G3), those 
using more than one pad, a diaper, or a condom catheter. 
Daytime continence (DTC) and nighttime continence 
(NTC) were evaluated separately.
Voiding pattern and catheterization
Micturition was evaluated primarily at consultation vis-
its, where information about urinary loss, catheterization 
need and spontaneous voiding was acquired. Clean inter-
mittent self-catheterization was started for those with a 
post-micturitional residue of more than 150 mL or recur-
rent urinary tract infections (UTIs).
Statistical analysis
Descriptive analyses were performed with SPSS version 
15.0 (SPSS Inc., Chicago, Illinois, USA), and were given 
as median and range for continuous quantitative vari-
ables and as percentages for non-numeric variables.
Results
Population
The median age of the men was 59 years (range 34–74); 
for women, it was 55 years (range 29–68). Median follow-
up was 75 months (range 3–204 months).
Elective OBS was performed in 118 patients; one 
patient undergoing bilateral distal ureterectomy suffered 
a rupture of a very fibrotic bladder wall, and subsequent 
cystectomy with ileal neobladder reconstruction was per-
formed. Bladder transitional cell carcinoma was the oper-
ative indication in the vast majority of patients (95.7 %). 
Only 30 patients (25.2 %) (25 men and 5 women) had a 
nerve-sparing surgery (23 bilateral, 7 unilateral).
Five patients presented preoperatively with posi-
tive lymph nodes, four of whom were treated with 
neo-adjuvant chemotherapy. Another 14 patients with 
muscle-invasive bladder cancer received neo-adjuvant 
chemotherapy. Patient demographics and disease char-
acteristics are described in Table  1. Because of cancer-
related and other cause deaths, the short- and long-term 
follow-up data differ.
Complication rates
Of the 119 patients, 47 (39.5 %) had early complications 
(≤3  months), and 59 of 111 evaluable patients (53.1  %) 
had late complications (>3 months). One patient died in 
the perioperative period due to perforation of the small 
intestine, which resulted in septic shock and acute myo-
cardial infarction. Seven other patients had no long-term 
follow-up (>3 months) because of death within the first 
year (>3  months) (5 patients; 4 cancer-related and 1 
death at home for unknown reasons), follow-up abroad 
(1 patient), or loss to follow-up (1 patient). All complica-
tions were counted separately, and some patients experi-
enced more than one complication.
Early complications
Table  2 gives an overview of the early complications 
and their management. In 119 patients, we registered 
15 major early complications (CCS III–V) compared to 
54 minor early complications (CCS I–II). Early pouch-
related complications occurred in 23 patients (19.3  %). 
UTI was the most frequent, occurring in 17 patients 
(14.3 %), with 14 cases classified as minor and 3 that led 
to urosepsis with intensive care admission. Non-pouch-
related early complications occurred in 33 patients 
(27.7  %). Minor complications were diverse and almost 
equally distributed among gastrointestinal (8.4  %), pul-
monary (6.7  %), and wound-related problems (5  %). Six 
Table 1 Patient demographics, disease characteristics, 
procedural data, and  pre- and  postoperative pathology 
results
Data are given as either median (range) or n (%)
Number of patients (Male/Female) 119 (102/17)
Age (years) Male: 59 (34–74)
Female: 55 (29–68)
Follow up (months) 75 (3–204)
Operative indication
 Transitional cell carcinoma 113 pts
 Interstitial cystitis 2 pts
 Vesicorectal fistula 1 pt
 Prostate cystadenoma 1 pt
 Persistant leakage from continent vesicostomy 1 pt
 Bladder wall calcification after BCG 1 pt
 Operation time (min) 210 (120–360)
 Blood loss (mL) 1100 (100–3600)
T stage Preoperative Postoperative Positive LN
T0 3 (2.7 %) 29 (25.7 %) 1/29 (3.4 %)
Tx 3 (2.7 %) 0 (0 %) 0 (0 %)
Tis 5 (4.4 %) 9 (7.9 %) 0/9 (0 %)
Ta 1 (0.8 %) 5 (4.4 %) 0/5 (0 %)
T1 22 (19.5 %) 15 (13.3 %) 1/15 (6.7 %)
T2 75 (66.4 %) 22 (19.5 %) 4/22 (18.2 %)
T3 4 (3.5 %) 29 (25.7 %) 12/29 (41.4 %)
T4 0 (0 %) 4 (3.5 %) 3/4 (75 %)
Total 113 (100 %) 113 (100 %) 21/113 (18.6 %)
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patients (5  %) presented with major complications, and 
open surgical exploration was necessary in four of them 
because of small bowel perforation, mesenterial bleeding, 
evisceration and removal of a textiloma.
Late complications
Table  3 gives an overview of all late complications and 
their management. We registered 56 major complications 
(CCS III–V) in 111 patients and 39 minor complica-
tions (CCS I–II). Late pouch-related complications were 
detected in 47 of 111 patients (42.3  %), most of which 
were infectious or obstructive (neovesicourethral or ure-
teroneovesical). Urosepsis was diagnosed in 3 patients 
(2.7  %) and relapsing UTIs or pyelonephritis in 26 
(23.4 %). Neovesicourethral stenosis (NUS) was noted in 
9.9 % (n = 11), acute urinary retention due to mucus clot 
in 5.4 % (n = 6), and ureteroneovesical stenosis in 5.4 % 
(n = 6). In two patients, a renal unit was lost because of 
long-term ureteroneovesical obstruction.
Late non-pouch-related complications were registered 
in 22 patients (19.8 %). Herniation of the laparotomy scar 
was surgically corrected with a mesh in 17 patients.
Pouch survival
Four patients had their N-pouch removed. Urethral 
tumor recurrence was noted in two patients in whom 
salvage urethropouchectomy and construction of an IC 
was performed. The other indications were neobladder 
hyper-contractility and neobladder–rectal fistula in a 
Table 2 Overview of  early complications (≤3  months) 
(pouch and non-pouch-related) by the Clavien–Dindo clas-
sification in 119 patients
Clavien–Dindo score (CCS) Number of complications (%)
Major
 V 1 (0.8 %)
 IV
  a 0 (0 %)
  b 3 (2.5 %)
 III
  a 3 (2.5 %)
  b 8 (6.7 %)
Minor
 II 34 (28.6 %)
 I 20 (16.8 %)
Complication N (%) CCS Treatment
Early pouch-related complications
Major
 Urosepsis 3 (2.5 %) IVb Intensive care
 Ureteroneovesical 
stenosis
2 (1.7 %) IIIb Re-implantation (1×)
Transureteroureterostomy 
(1×)
 Enteroneovesical  
fistula
1 (0.8 %) IIIb Open surgery
 Neovesicocutaneus 
fistula
1 (0.8 %) IIIb Endoscopic examination
 Neobladder bleeding 1 (0.8 %) IIIb Endoscopic examina-
tion + Rinsing
 Mucus retention 1 (0.8 %) IIIa Endoscopic examina-
tion + Rising
Minor
 Urinary tract infec-
tion (pyelonephritis, 
pouchitis, fever after 
removal of single-J 
stents)
14 (11.8 %) II Antibiotics
 Clot retention 1 (0.8 %) II Rinsing + Antibiotics
 Mucus retention 2 (1.7 %) I Rinsing
 Urinoma 1 (0.8 %) I Prolonged drainage
Early non-pouch-related complications
Major
 Death (small bowel 
perforation resulting 
in septic shock and 
myocardial infarction)
1 (0.8 %) V Open surgery (laparot-
omy) + Intensive care
 Mesenterial bleeding 1 (0.8 %) IIIb Open surgery
 Evisceration 1 (0.8 %) IIIb Open surgery
 Textilloma 1 (0.8 %) IIIb Open surgery
 Peptic ulcer 1 (0.8 %) IIIa Gastroscopy
 Pneumothorax 1 (0.8 %) IIIa Chest drain
Minor
 Pneumonia 5 (4.2 %) II Antibiotics
 Catheter sepsis 4 (3.4 %) II Antibiotics
Table 2 continued
Complication N (%) CCS Treatment
 Lung embolism 3 (2.5 %) II Low molecular weight 
heparin
 Ileus 2 (1.7 %) II Total parenteral nutrition 
(1×)
Jejunal catheter (1×)
 Fever (unknown origin) 1 (0.8 %) II Antibiotics
 Back pain 1 (0.8 %) II Epidural infiltration
 Acidosis 1 (0.8 %) II Intravenous bicarbonate
 Deep venous throm-
bosis
1 (0.8 %) II Low molecular weight 
heparin
 Wound abscess 1 (0.8 %) II Drainage + Antibiotics
 Wound problems 
(dehiscence, fat 
necrosis)
5 (4.2 %) I Vacuum therapy
 Ileus 5 (4.2 %) I Conservative
 Delirium 3 (2.5 %) I Oral medication
 Diarrhea 3 (2.5 %) I Conservative
 Catheter sepsis 1 (0.8 %) I Removal of deep venous 
catheter
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patient who underwent previous radiotherapy for pros-
tate cancer.
Urethral tumor recurrence was also diagnosed in 
another two patients, who had endoscopic resection of 
the lesions. All four patients with urethral tumor recur-
rence remained alive until last follow-up.
Continence rates
Among the male patients, for DTC at the 3-month interval, 
41.5 % of 94 patients were in G1, 40.5 % in G2, and 18 % 
in G3. At last follow-up, these rates were 83.1, 11.3, and 
5.6 %, respectively, in 71 patients (Fig. 2a). For NTC at the 
3-month interval, 11.2, 21.3, and 67.5 % of 89 male patients 
were in G1, G2, and G3, respectively. Of 71 patients evalu-
ated at last follow-up, these values were respectively 38, 
25.4, and 36.6 %. Of 26 incontinent patients (G3), 20 used 
diapers or condom catheters (Fig. 2b).
Among the women, for DTC at the 3-month interval, 
31.25, 31.25, and 37.5  % of 16 patients were in G1, G2, 
and G3, respectively; these percentages were 45.5, 36.3, 
and 18.2 % of 11 patients at last follow-up. Of note, the 
two incontinent patients at last follow-up eventually 
underwent a sling procedure for deteriorating stress 
incontinence (Fig.  3a). Regarding NTC at the 3-month 
interval, 26.6, 26.6, and 46.8 % of 15 women were respec-
tively in G1, G2, and G3, whereas these rates were 41.6, 
8.4, and 50 %, respectively, for 12 patients at last follow-
up. Five out of six women in G3 used diapers (Fig. 3b).
Hypercontinence and catheterization
Clean intermittent self-catheterization was necessary in 8 
out of 17 female patients (47 %), and none of them could 
void spontaneously. With the exclusion of six patients 
because of death or loss to follow-up, 18 out of 99 (18 %) 
Table 3 Overview of  late complications (>3  months) 
(pouch and non-pouch-related) by the Clavien–Dindo clas-
sification in 111 patients
Clavien–Dindo score (CCS) Number of complications (%)
Major
 V 1 (0.9 %)
 IV
  a 4 (3.6 %)
  b 0 (0 %)
 III
  a 2 (1.8 %)
  b 49 (44.1 %)
Minor
 II 28 (25.2 %)
 I 11 (9.9 %)
Complication N (%) CCS Treatment
Late pouch-related complications
Major
 Death (abscess forma-




sis + multiple organ 
failure)
1 (0.9 %) V Debridement + Intensive 
care
 Loss of renal unit 2 (1.8 %) IVa Conservative
 Ischemic perforation of 
neobladder
1 (0.9 %) IVa Laparotomy + Intensive 
care
 Urosepsis 1 (0.9 %) IVa Intensive care + Conserva-
tive therapy
 Pouch calculi 8 (7.2 %) IIIb Laser lithotripsy
 Neovesicourethral 
stenosis








6 (5.4 %) IIIb Ureteral reimplantation 
(4×)
Lifelong single-J stenting 
(2×)
 Stress incontinence 2 (1.8 %) IIIb Single incision mid-ure-
thral sling (1×)
Fascia lata sling (1×)
 Mucus obstruction 1 (0.9 %) IIIb Endoscopic evaluation
 Neovesicocutaneous 
fistula
1 (0.9 %) IIIb Open excision
 Neovesicorectal fistula 1 (0.9 %) IIIb Laparotomy + Conversion 
to ileal conduit
 Hypercontractile neo-
bladder with severe 
incontinence
1 (0.9 %) IIIb Laparotomy + Conversion 
to ileal conduit
 Ureterolithiasis 1 (0.9 %) IIIa Nephrostomy
 False-passage catheteri-
zation
1 (0.9 %) IIIa Endoscopic evaluation
Table 3 continued
Complication N (%) CCS Treatment
Minor
 Relapsing urinary tract 
infections and pyelone-
phritis
26 (23.4 %) II Antibiotics
 Urosepsis 2 (1.8 %) II Antibiotics + Fluid resus-
citation
 Mucus obstruction 5 (4.5 %) I Conservative
Late non-pouch-related complications
Major
 Wound herniation 17 (15.3 %) IIIb Open repair
 Small bowel obstruction 1 (0.9 %) IIIb Open adhesiolysis
Minor
 Diarrhea 6 (5.4 %) I Conservative
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male patients required catheterization of whom 12 could 
still void spontaneously. Of these hypercontinent men, 5 
(28 %) had NUS, 2 (11 %) had mucus retention while 11 
(61 %) had no clear reason. In the female hypercontinent 
population, no NUS was observed.
Discussion
Urinary diversion after RC can be performed in vari-
ous ways. For OIN, numerous techniques with differ-
ent intestinal segments and configurations have been 
described. The 2014 update of the European Association 
of Urology guidelines in muscle-invasive and metastatic 
bladder cancer recommends performing an OBS for both 
male and female patients who do not have any contrain-
dication or tumor in the urethra (grade B recommenda-
tion) (Witjes et al. 2014). Nevertheless, population-based 
studies from Sweden and the United States indicate that 
OBS is being performed much less frequently than IC, 
with a rate of approximately 15  % (Jahnson et  al. 2008; 
Gore et  al. 2009). OBS is generally preserved for highly 
motivated and cognitively capable patients. In a 17-year 
period, we performed 119 (14.7  % of total) consecu-
tive cystectomies with OBS; in the same time span, 691 
patients underwent IC in our institution. These relative 
numbers emphasize our thorough healthier and younger 
patient selection.
Cystectomy with OBS is an extensive surgery, and com-
plications are therefore common. The current results 
indicate early complications in more than one-third and 
late complications in more than half of patients. Espe-
cially, the late complication rates seem worse compared 
to other large series. Early complication rates ranging 
from 12.6 to 33.6 % and late complication rates between 
23.8 and 32 % have been reported at long-term follow-up 
(Studer et al. 2006; Hautmann et al. 1999; Shaaban et al. 
2003; Stein et al. 2004; Meyer et al. 2009). However, high 
rates of 44 and 61  % for early and 48 and 51  % for late 
complications have also been reported (Jensen et al. 2006; 
Nieuwenhuijzen et  al. 2008). The relatively long average 
follow-up time of 78.7 months may partially explain our 
elevated late complication rate. Almost all patients return 
for follow-up visits at our center where a very explicit 
and detailed history is noted in regular follow-up visits. 
This approach may have led to an increased detection of 
(minor) complications.
A more nuanced view emerges when we study these 
complications in detail. Of the 69 early complications 
encountered in 119 patients, only 15 (21.7 %) were major 
according to the CCS; thus, major early complications 
seem to be rather sporadic. Of the 95 late complications 
in 111 patients, 56 (58.9 %) were considered major (CCS 
III–V). In contrast to early complications, a significant 
portion of the late complications seemed to be serious. 
For example, 15.3 % of patients had open surgical repair 
of a wound herniation (1.5–6.4 % in other series) (Studer 
et  al. 2006; Hautmann et  al. 1999, 2011). Our NUS rate 
was 9.9 % whereas other large series have yielded stenosis 
rates ranging from 2.2 to 3.7 % (Studer et al. 2006; Haut-
mann et al. 1999). This rate is noteworthy because gener-
ally a simple buttonhole anastomosis was created, so that 
urethral stenosis rates would be expected to be similar to 
other series. These patients underwent re-intervention 
under (general) anesthesia (urethrotomy, transurethral 
resection and dilatation).
The late ureteroneovesical stenosis rate in this series 
was 5.4  %. Most patients underwent ureteral reimplan-
tation, and only two had a lifelong single-J stenting. The 
ureteroneovesical anastomosis was created by a simple 
refluxing end-to-end anastomosis, which is believed to 
have the lowest stenosis rates (Roth et al. 1997). An anti-
reflux anastomosis is not considered necessary for three 
reasons: An OIN is a low-pressure system that cannot 
provoke active reflux; the afferent ileal limb acts as an 
anti-reflux protection mechanism; and urine in an OIN 
is considered to be sterile (Hautmann et al. 2006). Steno-
sis rates are higher in anti-reflux valve anastomoses (9 %) 
Fig. 2 Male continence. a Daytime male continence. b Nighttime 
male continence
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while refluxing anastomoses stenosis rates are generally 
reported in no more than 3 % (Studer et al. 2006; Haut-
mann et al. 1999; Gakis and Stenzl 2010). Long-term and 
adequate follow-up could again explain the higher steno-
sis rate in our series.
Of particular interest are the continence rates. DTC 
rates are generally excellent in large series; continence 
is mostly achieved in more than 90 % of patients (both 
male and female), although definitions of continence 
may differ (Studer et  al. 2006; Hautmann et  al. 1999; 
Litwin et al. 1998; Shaaban et al. 2003; Abol-Enein and 
Ghoneim 2001). When pragmatically considering G1 
and G2 (maximum one pad a day) as being continent, 
DTC reaches up to 96  % in this series, consisting pre-
dominantly of men. At the 3-month interval, 82  % of 
male patients were continent, and this rate gradually 
reached a plateau at 95 %.
The female population in this study was small; there-
fore, no strong conclusions can be drawn for this patient 
group. During the first 6  months, DTC rates matched 
those of the male population. There seemed, however, 
to be a more substantial portion of female patients who 
continued to need a (safety) pad (G2), a number that 
continued to rise with longer follow-up. The steep rise 
in incontinence rates (G3) towards the last follow-up can 
probably be explained by de novo stress incontinence. 
Two female patients had sling surgery (many years after 
cystectomy) due to deteriorating stress incontinence.
At the 3-month interval, only 32 % of male and 53 % of 
female patients achieved NTC. Generally NTC improves 
more slowly than DTC (Hautmann et  al. 1999). NTC 
rates in male and female patients (including G1 and G2) 
were 63 and 73  %, respectively, at the 2-year interval, 
thereafter reaching a plateau.
We present good DTC rates (Figs. 2a, 3a) for the male 
patients, which are comparable to other series (Studer 
et  al. 2006; Hautmann et  al. 1999; Shaaban et  al. 2003; 
Gakis and Stenzl 2010; Abol-Enein and Ghoneim 2001). 
Our NTC rate of approximately 60–70  % (Figs.  2b, 3b) 
appears to be lower than the other series (Studer et  al. 
2006; Abol-Enein and Ghoneim 2001), but a formal com-
parison is not possible because the definition of incon-
tinence is pragmatic and subjective, and methods and 
follow-up times for assessing incontinence vary. In par-
ticular, nighttime incontinence has no clear definition 
in most series and can be influenced by nocturnal void-
ing, patient motivation and neobladder capacity. Perhaps 
these factors explain the rather low but probably realistic 
NTC rates in this report. Unfortunately, we have no accu-
rate data on nightly micturition rates, as frequent nightly 
micturition could improve nighttime incontinence rates.
As some authors have noted, hypercontinence is not 
an infrequent problem, especially among female patients, 
with rates of 16–33 % (Arai et al. 1999; Lee et al. 2004). 
This high percentage particularly in women can be due 
to kinking of the neobladder at the level of bladder neck 
due to a wider pelvis, absence of posterior support by the 
uterus, or injury of the autonomous nerves of the urethra. 
Most hypercontinent men remain able to void spontane-
ously, while women do not. All patients should be willing 
to self-catheterize before undergoing surgery. Because of 
the risk for nightly incontinence and self-catheterization, 
OBS should be recommended only to highly motivated 
patients.
This study has some limitations. With the retrospec-
tive design, we could not evaluate all patients for all data 
because of some deaths and missing data. Moreover, 
we acknowledge complication underreporting in ret-
rospective studies, and complications treated outside 
our center could have been missed. We used the CCS 
to standardize complication reporting and differentiate 
major and minor complications. Although this classifi-
cation was not originally developed for complications 
seen later than 90 days after surgery, CCS appears to be 
reasonably appropriate for reporting long-term com-
plications; however, Hautmann et  al. (2011) concluded 
Fig. 3 Female continence. a Daytime female continence. b Night-
time female continence
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that it seemed less suited for doing so. Nevertheless, 
there is no specific scoring system dedicated solely to 
the early/late complications of RC and urinary diver-
sion. Our rather high complication rates could arise 
from very accurate data gathering that, combined with a 
long follow-up, possibly has yielded more realistic rates 
than other series. As Donat (2007) proposed and Shab-
sigh et al. (2009) demonstrated, meticulously reporting 
short- and long-term complications gives better infor-
mation about true incidence and outcome not only in 
RC series but also in other uro-oncological procedures.
Conclusion
We present a retrospective analysis of 119 patients who 
underwent the Leuven N-pouch with long-term follow-
up. Complication rates were relatively high, reflecting a 
strict and meticulous follow-up scheme. Good DTC rates 
for male patients were achieved, but NTC rates were less 
than ideal. High complication and nighttime inconti-
nence rates strongly support reserving OBS only for thor-
oughly selected patients who can self-catheterize .
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